Catalent offers end-to-end solutions to accelerate drug development and market entry, with specialization in handling highly potent, hormonal, and cytotoxic compounds, integrating comprehensive risk assessment and controls for management and containment.
Catalent is the leading partner for drug development, delivery and supply in the global pharmaceutical and biotechnology industries.
With its broad experience, technological and scientific expertise, and a history of more than 80 years in pharmaceutical delivery solutions, Catalent helps customers with a wide range of services, including API and particle size optimization, formulation development, as well as drug delivery technology and final dose form design. Partnering with innovators from the earliest stages of the drug development process and throughout a drug’s lifecycle, Catalent provides end-to-end solutions to accelerate programs to clinic and to market.
Catalent has more than 20 years of experience in highly potent product development and commercialization, and offers integrated analytical, manufacturing, clinical supply solutions, and global supply chain assurance. In that time, it has worked on more than 300 compounds with an occupational exposure limit of less than 10 µg/m3 at its network of 12 specialized facilities, which includes a state-of-the-art site in Greenville, N.C. with extensive potent drug handling capabilities.